HRT Financial’s MIRA Pharmaceuticals MIRA Stock Holding History

HRT Financial’s Portfolio MIRA Stock Details MIRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-13,450	Closed	-$12K	–	5446
2026 Q2	$12K	Buy	+13,450	New	+$13.6K	﹤0.01%	3973
2024 Q2	–	Sell	-30,651	Closed	-$33K	–	2747
2024 Q1	$33K	Buy	+30,651	New	+$33.3K	﹤0.01%	1973

Other funds holding MIRA

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

CSI

Cross Staff Investments Pittsford, New York $168M AUM 14.41% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $67.2B AUM 18.61% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

First American Bank Dundee, Illinois $1.81B AUM 24.18% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 22.25% 1-Year Est. Return

HRT Financial's MIRA Position: Q3 2026 in Review

HRT Financial sold out of MIRA Pharmaceuticals (MIRA) in Q3 2026, closing a stake of 13,450 shares — an estimated $12K sold.

HRT Financial first reported a position in MIRA in Q1 2024 and held it in 2 quarters. The position peaked at $33K in Q1 2024. 18 funds tracked by Wall St. Rank hold MIRA as of Q3 2026.

HRT Financial reported no remaining MIRA Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
HRT Financial sold 13,450 MIRA Pharmaceuticals shares in Q3 2026, an estimated $12K.
HRT Financial first reported a position in MIRA Pharmaceuticals in Q1 2024 and held it in 2 quarters.
HRT Financial's MIRA Pharmaceuticals position peaked at $33K in Q1 2024.
18 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.